Axalta Coating Systems
AXTA
$31.68
-3.41%
Axalta Coating Systems Ltd. is a global manufacturer, marketer, and distributor of high-performance coatings systems, operating within the specialty chemicals industry. The company is a leading independent coatings provider with a distinct position across two core segments: Performance Coatings, serving the fragmented refinish and industrial markets, and Mobility Coatings, supplying original equipment manufacturers (OEMs) of light and commercial vehicles. The current investor narrative centers on the company's cyclical exposure to global automotive production and industrial activity, with debates likely focused on its ability to navigate raw material cost inflation, execute pricing actions to protect margins, and capitalize on secular trends like electric vehicle adoption and sustainable coating solutions.…
AXTA
Axalta Coating Systems
$31.68
AXTA 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Axalta Coating Systems's 12-month outlook, with a consensus price target around $36.86 and implied upside of +16.3% versus the current price.
Average Target
$36.86
0 analysts
Implied Upside
+16.3%
vs. current price
Analyst Count
—
covering this stock
Price Range
$30 - $44
Analyst target range
Insufficient analyst coverage data is available to form a consensus view. The provided data includes estimated EPS and revenue ranges for five analysts but lacks critical components such as the number of analysts providing ratings (Buy/Hold/Sell), a consensus recommendation, and most importantly, price targets. The absence of this data typically indicates limited institutional coverage, which is common for mid-cap companies like AXTA with a market cap of approximately $7.0 billion. This limited coverage can lead to higher stock price volatility and less efficient price discovery, as fewer professional opinions are shaping the market's view of the company's fair value.
Bulls vs Bears: AXTA Investment Factors
The evidence for AXTA presents a classic tension between a powerful technical recovery and lingering fundamental caution. The bull case is driven by strong momentum, an attractive forward P/E multiple based on analyst EPS expectations, and solid underlying profitability. The bear case hinges on the alarming negative PEG ratio, high volatility, and the stock's proven sensitivity to cyclical downturns. Currently, the technical momentum and valuation story provide stronger near-term evidence, but the single most important tension is the market's expectation of nearly doubling earnings (implied by the forward P/E) versus the warning signal from the negative PEG ratio. The resolution of this discrepancy—whether the company delivers the projected $3.47 EPS—will determine the next major directional move.
Bullish
- Strong Momentum Near 52-Week High: The stock has surged 36.71% over the past three months and is trading at $34.78, just 2.6% below its 52-week high of $35.72. This powerful recovery from the March low of $25.44 signals a decisive reversal of the prior downtrend and strong buying pressure.
- Attractive Forward P/E Implied by Analyst EPS: Based on the analyst consensus EPS estimate of $3.47, the forward P/E is 12.38x, a significant discount to the trailing P/E of 18.46x. This implies the market is pricing in a substantial 88% year-over-year earnings increase, offering a compelling valuation if the company delivers.
- Robust Balance Sheet and Liquidity: The company maintains a strong current ratio of 2.06, indicating ample short-term liquidity to meet obligations. A debt-to-equity ratio of 1.45 shows moderate leverage, which is manageable given the company's profitability and ROE of 16.11%.
- Solid Profitability and Operating Margin: Axalta demonstrates consistent profitability with a net margin of 7.39% and a healthy operating margin of 14.93%. The gross margin of 32.64% provides a solid foundation for absorbing potential raw material cost pressures.
Bearish
- Negative PEG Ratio Signals Growth Concerns: The PEG ratio is deeply negative at -10.95, a major red flag. This anomaly typically occurs when earnings growth is expected to be negative or when the P/E ratio is misaligned with growth projections, casting doubt on the sustainability of the current valuation.
- High Volatility and Beta Above Market: With a beta of 1.26, AXTA is 26% more volatile than the broader market. This elevated volatility, combined with a recent 28.48% maximum drawdown, indicates the stock carries higher risk, especially during market downturns or sector-specific headwinds.
- Limited Analyst Coverage and Price Discovery: Only five analysts provide estimates, and critical consensus ratings and price targets are unavailable. This limited coverage can lead to inefficient price discovery and higher volatility, as fewer professional opinions anchor the stock's fair value.
- Cyclical Exposure and Recent Sharp Correction: The stock's business is tied to cyclical automotive and industrial markets. The severe 28.8% correction from February's high to the March low demonstrates its vulnerability to economic slowdowns or sector rotations, a risk that remains present.
AXTA Technical Analysis
The stock is in a pronounced recovery phase from a significant correction, having rebounded 36.71% over the past three months from a low near $25.44. As of the latest close of $34.78, the price is trading at approximately 97% of its 52-week high of $35.72, indicating it is testing a major resistance level after a powerful rally. This positioning near the highs suggests strong momentum but also raises the risk of a pullback if the resistance holds. Recent momentum is exceptionally strong and diverges from the longer-term trend, with a 25.29% gain over the past month far outpacing the 18.30% one-year return, signaling a potential trend acceleration or reversal from the prior downtrend. The stock's beta of 1.26 confirms it is approximately 26% more volatile than the broader market, which is relevant for risk assessment during this volatile recovery phase. Key technical levels are clearly defined, with immediate resistance at the 52-week high of $35.72 and support at the 52-week low of $24.94. A decisive breakout above $35.72 would confirm the recovery trend and could open the path to further gains, while a failure and reversal could see the stock retest support levels established during the March sell-off.
Beta
1.24
1.24x market volatility
Max Drawdown
-28.5%
Largest decline past year
52-Week Range
$25-$36
Price range past year
Annual Return
+5.5%
Cumulative gain past year
| Period | AXTA Return | S&P 500 |
|---|---|---|
| 1m | -5.8% | +0.6% |
| 3m | +6.8% | +3.4% |
| 6m | -5.8% | +7.1% |
| 1y | +5.5% | +16.4% |
| ytd | -4.0% | +8.3% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
AXTA Fundamental Analysis
Data not available for a detailed quarterly revenue and growth trajectory analysis. Specific figures for recent quarterly revenue, year-over-year growth rates, and segment performance are not provided in the dataset, preventing an assessment of whether growth is accelerating or decelerating. Profitability metrics indicate the company is marginally profitable with a net margin of 7.39% and a gross margin of 32.64%, but without sequential quarterly data, the trend of margin expansion or compression cannot be determined. The trailing Price-to-Earnings (P/E) ratio of 18.46x and a forward P/E of 12.38x suggest the market anticipates earnings growth, though the negative PEG ratio of -10.95 is a notable anomaly that warrants caution. The balance sheet shows moderate financial leverage with a debt-to-equity ratio of 1.45, and strong short-term liquidity evidenced by a current ratio of 2.06. However, key cash flow figures such as free cash flow and return on equity (16.11%) are provided as static points without a trend, limiting the analysis of whether cash generation is sufficient to fund operations and growth internally.
Quarterly Revenue
N/A
N/A
Revenue YoY Growth
N/A
YoY Comparison
Gross Margin
N/A
Latest Quarter
Free Cash Flow
N/A
Last 12 Months
Open an Account, get $2 TSLA now!
Valuation Analysis: Is AXTA Overvalued?
Given a positive net margin, the primary valuation metric is the Price-to-Earnings (P/E) ratio. The stock trades at a trailing P/E of 18.46x and a forward P/E of 12.38x; the significant discount of the forward multiple implies the market expects a substantial year-ahead earnings increase, aligning with the analyst consensus EPS estimate of $3.47. Peer comparison data for industry average multiples is not available in the provided dataset, preventing a determination of whether AXTA trades at a premium or discount to its specialty chemicals sector. Historical valuation context is also unavailable due to missing historical ratios data, so it cannot be assessed if the current P/E is near the top or bottom of its own historical range, which would help gauge if the stock is pricing in optimistic or pessimistic expectations.
PE
18.5x
Latest Quarter
vs. Historical
N/A
5-Year PE Range 17x~59x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
9.4x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Axalta faces moderate financial risk with a debt-to-equity ratio of 1.45, though this is mitigated by strong liquidity (current ratio of 2.06). The primary operational risk is margin pressure; while the gross margin is 32.64%, the company remains exposed to volatile raw material costs in the chemicals industry. Furthermore, the negative PEG ratio of -10.95 represents a significant valuation risk, signaling potential misalignment between its price and expected growth, which could lead to multiple compression if earnings disappoint. The company's heavy reliance on the cyclical Mobility Coatings segment (its largest revenue contributor) creates earnings volatility tied to global automotive production cycles.
Market & Competitive Risks: The stock's beta of 1.26 confirms it is more volatile than the market, amplifying downside during broad sell-offs. Trading near its 52-week high after a 36.7% rally, it faces valuation compression risk if the momentum falters. As a mid-cap specialty chemical company with limited analyst coverage, it is susceptible to lower liquidity and wider bid-ask spreads compared to larger peers, potentially exacerbating price swings. Competitive risks are inherent in the fragmented coatings market, where pricing power can be challenged, and technological shifts toward sustainable solutions require continuous R&D investment.
Worst-Case Scenario: The worst-case scenario involves a simultaneous downturn in global automotive production (hitting the Mobility segment) and an inability to pass through raw material cost inflation (pressuring the 32.64% gross margin), leading to a significant earnings miss versus the $3.47 consensus. This could trigger a re-rating from the current forward P/E of 12.38x to a more distressed multiple, compounded by the stock's high beta. A realistic downside could see the stock retest its 52-week low of $24.94, representing a potential loss of approximately -28% from the current price of $34.78. The recent max drawdown of -28.48% provides a historical precedent for this magnitude of decline.